Neurodevelopmental disorders (NDDs), such as intellectual disability, autism spectrum disorders, аttention deficit hyperactivity disorder (ADHD), schizophrenia, and bipolar disorder, represent a group of complex and heterogeneous disorders caused by changes in early brain development. The prevalence of NDDs is 10-15%, with a tendency to increase in the last few years. NDDs have a high socio-economic impact and affect the cognitive, social, and motor abilities of the patients. Treatments for NDDs are focused on the symptoms because the molecular mechanisms underlying NDDs are still poorly understood.
